SEC-sourced researchBeta
PRME
Prime Medicine, Inc.
Company comparison ↗
Data passport
- CIK
- 0001894562
- Exchange
- Nasdaq
- Business activity
- — · SIC 2836
- Financial inputs
- 6/6
- Filing date
- Mar 3, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 2,983,000.0000 | Mar 3, 2026 |
| December 2025 | 4,632,000.0000 | Mar 3, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 4,632,000.0000 | -201,142,000.0000 | -162,564,000.0000 | 342,733,000.0000 | 221,865,000.0000 | Mar 3, 2026 |
| December 2024 | 2,983,000.0000 | -195,882,000.0000 | -122,865,000.0000 | 297,508,000.0000 | 144,359,000.0000 | Mar 3, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $4.63M | December 2025 | Mar 3, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $2.98M | December 2024 | Mar 3, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$201.14M | December 2025 | Mar 3, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$162.56M | December 2025 | Mar 3, 2026 | 10-K |
| Total assetsAssets | $342.73M | December 2025 | Mar 3, 2026 | 10-K |
| Total liabilitiesLiabilities | $221.87M | December 2025 | Mar 3, 2026 | 10-K |